Targeted oligonucleotide delivery in human lymphoma cell lines using a polyethyleneimine based immunopolyplex

Journal of Controlled Release

Volumn 83, Issue 1, 2002, Pages 133-146

  Guillem, Vicent M ^a,b   Tormo, Mar ^a   Moret, Inés ^b   Benet, Isabel ^a   García Conde, Javier ^a   Crespo, Antonio ^b   Alio, Salvador F ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Immunopolyplex; Oligonucleotide; Polyethyleneimine; Streptavidin; Targeting

Indexed keywords

ANTIBODY; CD3 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; OLIGONUCLEOTIDE; POLYETHYLENEIMINE DERIVATIVE;

ARTICLE; CELL MUTANT; CONTROLLED STUDY; DNA VECTOR; ENDOCYTOSIS; FLUORESCENCE; GENE TRANSFER; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA CELL LINE; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL;

DRUG DELIVERY SYSTEMS; GENETIC VECTORS; HUMANS; LYMPHOMA; OLIGONUCLEOTIDES; POLYETHYLENEIMINE; TUMOR CELLS, CULTURED;

EID: 0037130560     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00170-0     Document Type: Article

References (45)

1. Godbey W.T., Mikos A.G. Recent progress in gene delivery using nonviral transfer complexes. J. Controlled Release. 72:2001;115-125.
2. Gokhale P.C., Soldatenkov V., Wang F.H., Rahman A., Dritschilo A., Kasid U. Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancer. Gene Ther. 4:1997;1289-1299.
3. Tormo M., Tari A.M., McDonnell T.J., Cabanillas F., Garcia-Conde J., Lopez-Berestein G. Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation. Leuk. Lymphoma. 30:1998;367-379.
4. Kronenwett R., Steidl U., Kirsch M., Sczakiel G., Haas R. Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset. Blood. 91:1998;852-862.
5. Gebhart C.L., Kabanov A.V. Evaluation of polyplexes as gene transfer agents. J. Controlled Release. 73:2001;401-416.
6. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc. Natl. Acad. Sci. USA. 92:1995;7297-7301.
7. von Harpe A., Petersen H., Li Y., Kissel T. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Controlled Release. 69:2000;309-322.
8. Lee H., Jeong J.H., Park T.G. A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. J. Controlled Release. 76:2001;183-192.
9. Zelphati O., Szoka F.C. Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA. 93:1996;11493-11498.
10. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine) and its role in gene delivery. J. Controlled Release. 60:1999;149-160.
11. Kabanov A.V., Kabanov V.A. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug. Chem. 6:1995;7-20.
12. Kavanov A.V., Szoka F.C., Seymour L.W. Interpolielectrolyte complexes for gene delivery: polymer aspects of transfection activity. Kabanov A.V., Felgner P.L., Seymour L.W., Self-assembling Complexes for Gene Delivery. From Laboratory to Clinical Trial. 1998;197-218 John Wiley & Sons, Chichester.
13. Labat-Moleur F., Steffan A.M., Brisson C., Perron H., Feugeas O., Furstenberger P., Oberling F., Brambilla E., Behr J.P. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther. 3:1996;1010-1017.
14. Mislick K.A., Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA. 93:1996;12349-12354.
15. Ogris M., Steinlein P., Carotta S., Brunner S., Wagner E. A versatile assay to study cellular uptake of gene transfer complexes by flow cytometry. Biochim. Biophys. Acta. 1474:2000;237-243.
16. Ma D.D., Wei A.Q. Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes. Leuk. Res. 20:1996;925-930.
17. Aliño S.F., Crespo J., Tarrasón G., Blaya C., Adán J., Escrig E., Benet M., Crespo A., Piulats J. Oligonucleotide-entrapped immunoliposome delivered by mini-osmotic pump improves the survival of SCID mice bearing human leukemia. Tumor Targeting. 4:1999;1-9.
18. Simoes S., Slepushkin V., Pires P., Gaspar R., Pedroso de Lima M.C., Düzgünes N. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Ther. 6:1999;1798-1807.
19. Wagner E., Zenke M., Cotten M., Beug H., Birnstiel M.L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA. 87:1990;3410-3414.
20. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., Buchberger M., Wagner E. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4:1997;409-418.
21. Kircheis R., Schuller S., Brunner S., Ogris M., Heider K.H., Zauner W., Wagner E. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. 1:1999;111-120.
22. Zanta M.A., Boussif O., Adib A., Behr J.P. In vitro gene delivery to hepatocytes with galactosylated polyethyleneimine. Bioconj. Chem. 8:1997;839-844.
23. Ogris M., Steinlein P., Kursa M., Mechtler K., Kircheis R., Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 10:1998;1425-1433.
24. Ogris M., Brunner S., Schuller S., Kircheis R., Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:1999;595-605.
25. Erbacher P., Bettinger T., Belguise-Valladier P., Zou S., Coll J.L., Behr J.P., Remy J.S. Transfection and physical properties of various saccharide,poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1:1999;210-222.
26. Li S., Tan Y., Viroonchatapan E., Pitt B.R., Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am. J. Physiol. Lung Cell Mol. Physiol. 278:2000;504-511.
27. O'Neill M.M., Kennedy C.A., Barton R.W., Tatake R.J. Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethyleneimine. Gene Ther. 8:2001;362-368.
28. Wojda U., Miller J.L. Targeted transfer of polyethylenimine-avidin-DNA bioconjugates to hematopoietic cells using biotinylated monoclonal antibodies. J. Pharm. Sci. 89:2000;674-681.
29. Kircheis R., Blessing T., Brunner S., Wightman L. E. Wagner, Tumor targeting with surface-shielded ligand-polycation DNA complexes. J. Controlled Release. 72:2001;165-170.
30. Woodle M.C., Scaria P., Ganesh S., Subramanian K., Titmas R., Cheng C., Yang J., Pan Y., Weng K., Gu C., Torkelson S. Sterically stabilized polyplex: ligand-mediated activity. J. Controlled Release. 74:2001;309-311.
31. Guillem V.M., Tormo M., Revert F., Benet I., Garcia-Conde J., Crespo A., Alino S.F. Polyethyleneimine Based Immunopolyplex for Targeted Gene Transfer in Human Lymphoma Cell Lines. J. Gene Med. 4:2002;170-182.
32. Tang M.X., Szoka F.C. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 4:1997;823-832.
33. Galderisi U., Cascino A., Giordano A. Antisense oligonucleotides as therapeutic agents. J. Cell. Physiol. 181:1999;251-257.
34. Faria M., Spiller D.G., Dubertret C., Nelson J.S., White M.R., Scherman D., Helene C., Giovannangeli C. Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo. Nat. Biotechnol. 19:2001;40-44.
35. Faria M., Wood C.D., Perrouault L., Nelson J.S., Winter A., White M.R., Helene C., Giovannangeli C. Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc. Natl. Acad. Sci. USA. 97:2000;3862-3867.
36. Klasa R.J., Bally M.B., Ng R., Goldie J.H., Gascoyne R.D., Wong F.M. Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide. Clin. Cancer. Res. 6:2000;2492-2500.
37. Bloem A., Lockhorst H. Bcl-2 antisense therapy in multiple myeloma. Pathol. Biol. (Paris). 47:1999;216-220.
38. Klemm A.R., Young D., Lloyd J.B. Effects of polyethyleneimine on endocytosis and lysosome stability. Biochem. Pharmacol. 56:1998;41-46.
39. Godbey W.T., Wu K.K., Mikos A.G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA. 96:1999;5177-5181.
40. Kichler A., Leborgne C., Coeytaux E., Danos O. Polyethyleneimine-mediated gene delivery: a mechanistic study. J. Gene Med. 3:2001;135-144.
41. Pollard H., Remy J.S., Loussouarn G., Demolombe S., Behr J.P., Escande D. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273:1998;7507-7511.
42. Smythe E., Warren G. The mechanism of receptor-mediated endocytosis. Eur. J. Biochem. 202:1991;689-699.
43. Liu Y., Mounkes L.C., Liggitt H.D., Brown C.S., Solodin I., Heath T.D., Debs R.J. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol. 15:1997;167-173.
44. Ross P.C., Hui S.W. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. 6:1999;651-659.
45. Ogris M., Steinlein P., Carotta S., Brunner S., Wagner E. DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS PharmSci. 3:2001;E21.